secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001493152-25-018156
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa CMO Pablo Guzman resigns Oct 10, 2025 to focus on family
----------------------------------------------------------------

- Pablo Guzman, M.D., resigned as CMO and SVP of Medical Affairs, effective October 10, 2025.
- Dr. Guzman joined ZyVersa in January 2015 with over 35 years of medical experience.
- Resignation reason: personal (spend time with family and travel); no replacement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/0001493152-25-018156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225018156/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer